天然产物醌类Quinones
Menadione (Synonyms: 维生素K3; Vitamin K3) 纯度: 98.07%
Menadione是合成的萘醌,可在体内转化为活性维生素K2。
Menadione Chemical Structure
CAS No. : 58-27-5
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1-0.5 mg) | Apply now | ||
10 mM * 1 mL in DMSO | ¥550 | In-stock | |
500 mg | ¥500 | In-stock | |
1 g | ¥650 | In-stock | |
5 g | 询价 | ||
10 g | 询价 |
* Please select Quantity before adding items.
Menadione 相关产品
•相关化合物库:
- Natural Product Library Plus
- Drug Repurposing Compound Library Plus
- FDA-Approved Drug Library Plus
- FDA-Approved Drug Library Mini
- Bioactive Compound Library Plus
- Metabolism/Protease Compound Library
- Natural Product Library
- FDA-Approved Drug Library
- Human Endogenous Metabolite Compound Library
- Drug Repurposing Compound Library
- Anti-COVID-19 Compound Library
- NMPA-Approved Drug Library
- Orally Active Compound Library
- FDA Approved & Pharmacopeial Drug Library
- Food-Sourced Compound Library
生物活性 |
Menadione, a synthetic naphthoquinone, can be converted to active vitamin K2 in vivo. Target: Others Menadione (Vitamin K3) is a synthetic analogue of of 1,4-naphthoquinone with a methyl group in the 2-position. Menadione is used as a phosphatase inhibitor and an inhibitor of mitochondrial DNA polymerase γ (pol γ). Menadione can be used as an oxidative injury (free radical generator) inducing agent [1]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
172.18 |
||||||||||||||||
Formula |
C11H8O2 |
||||||||||||||||
CAS 号 |
58-27-5 |
||||||||||||||||
中文名称 |
甲萘醌;维生素K3 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 50 mg/mL (290.39 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|